Published in S Afr Med J on August 11, 1984
Templating α-amylase peptide inhibitors with organotin compounds. J Biol Inorg Chem (2011) 0.75
Bio-availability of three formulations of glibenclamide. S Afr Med J (1989) 1.39
Experience with the intensive care management of organophosphate insecticide poisoning. S Afr Med J (1981) 1.12
Ligation of the patent ductus arteriosus in premature infants: report of 45 cases. J Pediatr Surg (1973) 1.10
[Free-flow electrophoresis. I. Theoretical and experimental investigations of the influence of mechanical and electrokinetic variables on the efficiency of the method]. Hoppe Seylers Z Physiol Chem (1975) 0.96
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarin. Br J Clin Pharmacol (1995) 0.94
The pharmacology of recombinant hirudin, a new anticoagulant. S Afr Med J (1990) 0.92
Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.92
South African multicentre trial with Voltaren in osteo-arthritis of the knee. S Afr Med J (1974) 0.90
Caffeine in sport. Urinary excretion of caffeine in healthy volunteers after intake of common caffeine-containing beverages. S Afr Med J (1988) 0.88
Pharmacokinetics of acarbose. Part I: Absorption, concentration in plasma, metabolism and excretion after single administration of [14C]acarbose to rats, dogs and man. Arzneimittelforschung (1989) 0.86
The effects of forskolin eye drops on intra-ocular pressure. S Afr Med J (1987) 0.86
Does cimetidine alter the cardiac response to exercise and propranolol? S Afr Med J (1979) 0.85
Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. S Afr Med J (1981) 0.85
A correlative study of serum digoxin levels and electrocardiographic measurements. S Afr Med J (1975) 0.85
Single and divided doses of penbutolol. Clin Pharmacol Ther (1979) 0.85
A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. S Afr Med J (1974) 0.84
Pharmacokinetic and pharmacodynamic implications of long-term administration of non-steroidal anti-inflammatory agents. Int J Clin Pharmacol Biopharm (1977) 0.84
Pharmacokinetics of ramipril in the elderly. Am J Cardiol (1987) 0.83
Comparative bio-availability of four formulations of furosemide. S Afr Med J (1985) 0.82
Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. Am J Hypertens (1997) 0.82
The effect of penbutolol on glomerular filtration. S Afr Med J (1981) 0.81
Absolute bioavailability of a new high dose methylprednisolone tablet formulation. Int J Clin Pharmacol Ther (1994) 0.80
No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin. J Clin Pharmacol (1995) 0.80
Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage. Hum Toxicol (1983) 0.79
[Effects of smoking and oral contraceptives on plasma and whole blood viscosity. Rheologic studies on normal subjects]. Med Welt (1978) 0.79
The effect of fasting on total serum bilirubin concentrations. Br J Clin Pharmacol (1995) 0.79
Pharmacokinetic aspects of the interaction between clobazam and cimetidine. Eur J Clin Pharmacol (1983) 0.79
Ibuprofen bio-availability. A comparison of Brufen and Inza. S Afr Med J (1986) 0.78
Paracetamol overdose: protective effect of concomitantly ingested antimuscarinic drugs and codeine. Hum Toxicol (1983) 0.78
Severe mefenamic acid poisoning. A case report. S Afr Med J (1985) 0.78
Letter: Ethyl alcohol: contamination of blood specimens. S Afr Med J (1976) 0.78
Lack of interaction between ramipril and simvastatin. Eur J Clin Pharmacol (1994) 0.77
[Mode of action of pentoxifyllin]. Med Monatsschr (1975) 0.77
Inhibition of starch absorption by tendamistate (an alpha-amylase inactivator). S Afr Med J (1983) 0.76
Effect on salivary enzymes of alpha-amylase inhibitor HOE 467. Lancet (1983) 0.76
Towards standardisation of pre- and post-analytical variables in the assessment of lipid risk factors for ischaemic heart disease. S Afr Med J (1988) 0.76
Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol. Arzneimittelforschung (1995) 0.76
Inhibition of starch absorption by alpha-amylase inactivator given with food. Lancet (1983) 0.76
Multiple doses of trandolapril do not affect warfarin pharmacodynamics. S Afr Med J (1995) 0.76
Availability of phendimetrazine from sustained and non-sustained action formulations. S Afr Med J (1975) 0.76
Etomidate as anaesthetic induction agent in open-heart surgery. S Afr Med J (1980) 0.76
Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril. Br J Clin Pharmacol (1993) 0.76
No influence of pantoprazole on the pharmacokinetics of phenytoin. Int J Clin Pharmacol Ther (1995) 0.76
Digoxin concentrations in serum and saliva: relationship to ECG changes and dosage in healthy volunteers. Br J Clin Pharmacol (1976) 0.75
Salivary digoxin concentrations. Br J Clin Pharmacol (1976) 0.75
Effects of tendamistate (alpha-amylase inactivator) on starch metabolism. Br J Clin Pharmacol (1983) 0.75
Ingestion of codeine and salicylic acid causing convulsions and coma. A case report. S Afr Med J (1984) 0.75
Minimization--a method of obtaining comparable groups in clinical trials. S Afr Med J (1984) 0.75
Statistical significance versus clinical relevance. Part III. Methods for calculating confidence intervals. S Afr Med J (1989) 0.75
Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics. S Afr Med J (1988) 0.75
Antagonism of diazepam by aminophylline in healthy volunteers. Anesth Analg (1984) 0.75
Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels. S Afr Med J (1974) 0.75
Statistical significance versus clinical relevance. Part II. The use and interpretation of confidence intervals. S Afr Med J (1989) 0.75
Statistical significance versus clinical relevance. Part I. The essential role of the power of a statistical test. S Afr Med J (1989) 0.75
Pharmacodynamics and tolerability of low doses of tendamistate given with starch. S Afr Med J (1984) 0.75
Effects of tendamistate (an alpha-amylase inactivator), guar and placebo on starch metabolism. S Afr Med J (1984) 0.75
Inhibition of atropine metabolism by organophosphate pesticides. Hum Toxicol (1983) 0.75
Materno-fetal cholinesterase inhibitor poisoning. Anesth Analg (1983) 0.75
Effects of piretanide on potassium balance in hypertension. S Afr Med J (1985) 0.75
GLC determination of phendimetrazine in serum. J Pharm Sci (1975) 0.75
[Plasma melatonin concentrations as additional biochemical markers for ovulation]. S Afr Med J (1993) 0.75
The effect of fructose on blood alcohol levels in man. S Afr Med J (1982) 0.75
Furosemide chronopharmacology. S Afr Med J (1982) 0.75
The use of low-dose acetazolamide to prevent mountain sickness. S Afr Med J (1995) 0.75
Acquisition and processing of cerebral blood flow data with a multichannel analyser and microcomputer. S Afr Med J (1974) 0.75
The use of renal enzymes as early indication of renal toxicity after multiple-dose administration of aspirin. S Afr Med J (1983) 0.75
Accurate placement of a lumbar epidural cannula without epidurograms. S Afr Med J (1983) 0.75
Pharmacodynamics and urine pharmacokinetics of three doses of piretanide. Eur J Clin Pharmacol (1983) 0.75
Comparative bio-availability of theophylline whole and halved sustained-release tablets. S Afr Med J (1987) 0.75
Oxprenolol plus ethanol causes no central nervous system depression--a comparison with lorazepam plus ethanol. S Afr Med J (1984) 0.75
Quantitative assessment of analgesia conferred by various analgesics, as determined by blocking the intra-arterial bradykinin-evoked pain-response in the rat. Eur J Pharmacol (1969) 0.75
Physostigmine and the adrenergic/antimuscarinic syndrome. A case report. S Afr Med J (1984) 0.75
Epidural fentanyl in the management of postoperative pain. S Afr Med J (1986) 0.75
Carbamazepine and its major metabolites in plasma: a summary of eight years of therapeutic drug monitoring. Ther Drug Monit (1983) 0.75
Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives. Int J Clin Pharmacol Ther Toxicol (1993) 0.75
Drugs in sport. The first 5 years of testing in South Africa. S Afr Med J (1988) 0.75
Dettol (chloroxylenol and terpineol) poisoning in a pregnant patient. A case report. S Afr Med J (1984) 0.75
The metabolism of atropine in man. J Pharm Pharmacol (1986) 0.75